Clinical Trials Logo

Clinical Trial Summary

American Diabetes Association and American Clinical Endocrinology American Association of Clinical Endocrinologists, treatment and care of individuals with diabetes in achieving their goals; regulation of nutrition, regulation of physical activity, pharmacological treatment, diabetes education, continuous monitoring and health checks should be done. emphasizes (3,4). Individuals with diabetes receive diabetes self-management education and support when necessary. they should. Diabetes self-management is the knowledge, skills and abilities necessary for the individual's self-care. It is defined as the facilitation process (4,5). Competent and skilled in self-management individuals with diabetes can improve their health outcomes. American Diabetes Association (ADA), diabetes self-management education necessary for the self-care of people with diabetes. take an individual-centered approach and make joint decisions to facilitate knowledge, skills and abilities It defines it as a process based on diagnosis, starting at the diagnosis stage and continuing (5). The goal of diabetes self-management is to introduce new skills and abilities that support diabetes patients' self-management goals. Developing behaviors and forming habits. General objectives of diabetes self-management education On the other hand, it enables individuals diagnosed with diabetes to make informed decisions, problem solving, personal care behavior, metabolic outcomes, health status and quality of life to improve (5). To strengthen the diabetes patient by providing self-management needs knowledge, skills and motivation about the disease. Counseling for nurses ability of the patient to adapt to his/her illness and self-care by doing and educating provides access (6). Coaching sessions to strengthen diabetes self-management and diabetes is applied. The coach is committed to maximizing the client's strengths, To ensure that it is used fully through continuous education, to be more effective, new to develop skills and activities, to be ready for new responsibilities, and to self-management. It is the person who provides the necessary motivation (7). Life Coaching with Diabetes, about lifestyle with diabetes professional life coaching practices, aiming at behavior change in approaches (ICF-International Coaching Federation) is based on the basic principles and principles. life with diabetes coaching is used to help people who have been diagnosed with diabetes make the necessary changes in life through coaching. to give practical applications. Walt Disney is a goal setting coaching exercise. The work consists of 6 steps. These steps it is as follows. 1. Detection of the subject and 3 anchor methods 2. Dreamer + Ground Anchor + Separator 3. Planner + Ground Anchor + Separator 4. Critic + Ground Anchor + Separator 5. Brainstorming 6. Metatest


Clinical Trial Description

Expected benefits: Diabetes is a non-communicable disease that is increasing rapidly day by day. Providing support integrated with life coaching with diabetes will increase the awareness of people with diabetes and enable them to manage their diabetes. - Developing appropriate self-care activities (physical activity, medical nutrition, drug management, avoiding risky behaviors, etc.) by improving the self-management skills of the individual with diabetes, - The individual with diabetes becomes self-managing self-care practices, - Improving decision-making and problem-solving skills of individuals with diabetes, H0: Diabetes nurse coaching given to individuals with Type 2 Diabetes has no effect on HbA1c value and on strengthening diabetes. H1: Diabetes nurse coaching given to individuals with Type 2 Diabetes has an effect on HbA1c value and strengthening diabetes. The Universe of the Research The population of the study consists of patients with Type 2 Diabetes between the ages of 18-64 who applied to Ankara Pursaklar State Hospital Internal Medicine outpatient clinic. Sample Selection of the Research The sample size was calculated using G*Power Software (ver. 3.1.9.7). The effect size was calculated by using the mean and standard deviation values of the last test of the experimental and control groups of the 'Diabetes strengthening scale' used in the randomized controlled study by Zamanzadeh (2017), the sample of the study. The sample size required for the study was calculated as 34 patients, 17 patients for each group, in the power analysis performed with 95% confidence level and 5% tolerance. However, it was aimed to reach 21 individuals from each group with the foresight that there may be participant losses during the study process. To avoid bias in assigning the individuals to be included in the study to the groups, https://randomizer.org/ With the help of the help of 1-42, random numbers were generated as 2 groups and the incoming individuals will be assigned to the relevant groups. Data Collection Technique and Tools The data in the research will be collected through the data collection form, the diabetes empowerment scale, which was prepared based on the researcher's experiences and the literature. 1. Data collection form: It will be created by the researcher based on the literature. (such as age, gender, how many years have had diabetes). 2. Diabetes empowerment scale: The scale developed by Özcan and Korkmaz (2012); It has 3 sub-dimensions: management of psychosocial aspects in diabetes, level of dissatisfaction and readiness for change, setting and achieving diabetes goals. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05870293
Study type Interventional
Source Ankara Yildirim Beyazit University
Contact
Status Completed
Phase N/A
Start date May 1, 2023
Completion date July 1, 2023

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05666479 - CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
Completed NCT05647083 - The Effect of Massage on Diabetic Parameters N/A
Active, not recruiting NCT05661799 - Persistence of Physical Activity in People With Type 2 Diabetes Over Time. N/A
Completed NCT03686722 - Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin Phase 1
Completed NCT02836704 - Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose) Phase 4
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Completed NCT04562714 - Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy N/A
Completed NCT02009488 - Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM) Phase 1
Completed NCT05896319 - Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2 N/A
Recruiting NCT05598203 - Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes N/A
Completed NCT05046873 - A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People Phase 1
Terminated NCT04090242 - Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes N/A
Completed NCT04030091 - Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus Phase 4
Completed NCT03620357 - Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D) N/A
Completed NCT03604224 - A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT03620890 - Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy Phase 4
Withdrawn NCT05473286 - A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Completed NCT04531631 - Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes Phase 2